These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4309078)

  • 1. [The importance of initial chemotherapy in tuberculosis control programs].
    Anastasatu C
    Ann Ist Super Sanita; 1966; 2(2):458-70. PubMed ID: 4309078
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness of antibacterial therapy of lung tuberculosis in degenerated stage in children and adolescence].
    Nabokova LS
    Pediatr Akus Ginekol; 1968; 5():5-6. PubMed ID: 5310924
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effectiveness of prolonged antibacterial therapy in newly detected patients with active pulmonary tuberculosis].
    Kuropatkin IF; Chuprova KP
    Probl Tuberk; 1967; 45(9):32-5. PubMed ID: 5606475
    [No Abstract]   [Full Text] [Related]  

  • 4. [Primary resistance against tuberculostatic agents in Indonesia].
    The Kie Seng ; Tan Thiam Hok ; Yang She Yen
    Med Klin; 1967 Oct; 62(42):1622-3. PubMed ID: 4969644
    [No Abstract]   [Full Text] [Related]  

  • 5. [Modern tuberculosis therapy].
    Krohn J
    Tidsskr Nor Laegeforen; 1973 Dec; 93(35):2576-8. PubMed ID: 4772808
    [No Abstract]   [Full Text] [Related]  

  • 6. [Proceedings: Current status and perspectives of tuberculosis chemotherapy in Algeria].
    Larbaoui D; Chaulet P
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):139-46. PubMed ID: 4491711
    [No Abstract]   [Full Text] [Related]  

  • 7. Five cases of child tuberculosis caused by strains primarily resitant to all three main anti-tuberculosis drugs.
    Brander E; Aho K; Wasz-Höckert O
    Scand J Respir Dis; 1967; 48(1):76-80. PubMed ID: 4964559
    [No Abstract]   [Full Text] [Related]  

  • 8. Results of one-year chemotherapy in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Janczy S; Buraczewska M; Korlakowski J; Zych D; Krychniak W
    Pol Med J; 1966; 5(3):526-32. PubMed ID: 5920266
    [No Abstract]   [Full Text] [Related]  

  • 9. [Primary resistance to the major antitubercular drugs in pulmonary tuberculosis patients during 1961-1966].
    Jaroszewicz W; Buraczewska M; Pichulowa K; Pszonicka A; Zych D
    Gruzlica; 1968; 37(1):17-21. PubMed ID: 5720034
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical significance of the resistance to the classical tuberculostatics].
    Eule H
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):319-24. PubMed ID: 5897859
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug sensitivity in pulmonary tuberculosis. Incidence of primary and acquired drug-resistance in 1960-1963.
    Selroos O; Brander L
    Acta Tuberc Pneumol Scand; 1965; 46(3):197-206. PubMed ID: 5880140
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary resistance to major antituberculous drugs in patients with pulmonary tuberculosis in the years 1957-1964.
    Polończyk M
    Pol Med J; 1967; 6(3):604-9. PubMed ID: 6038083
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prophylactic and preventive measures in the fight against tuberculosis].
    Simon K
    Beitr Klin Erforsch Tuberk Lungenkr; 1968; 137(2):151-8. PubMed ID: 5748058
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preliminary findings and considerations on primary resistance to SM, INI, and PAS in the Provincial Antitubercular Association of Naples].
    Romano S; Grella G
    Rass Int Clin Ter; 1966 Dec; 46(23):1311-6. PubMed ID: 5997869
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative study of therapeutic effect and side actions of 1314 TH and 1321 TH in the initial therapy of tuberculosis].
    Sunahara S; Nagasawa S
    Saishin Igaku; 1969 Apr; 24(4):922-7. PubMed ID: 5807960
    [No Abstract]   [Full Text] [Related]  

  • 16. [Reasons for failures in chemotherapy of tuberculosis].
    Dissmann E
    Beitr Klin Erforsch Tuberk Lungenkr; 1968; 138(1):17-24. PubMed ID: 5728639
    [No Abstract]   [Full Text] [Related]  

  • 17. Cycloserine in the treatment of pulmonary tuberculosis.
    Aceves Ortega R; Cortés de la Peña F; Sanchez Ceceña S; Arreola Chavez C
    Scand J Respir Dis Suppl; 1970; 71():109-14. PubMed ID: 5271969
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative results of treatment of pulmonary tuberculosis with the compounds of benzoyl-PAS-Ca-isoniazide and streptomycin-isoniazid].
    Favez G; Gonin JD; Gubéran E; de Kalbermatten JP; Vulliémoz P; Willa C
    Schweiz Med Wochenschr; 1969 Feb; 99(5):150-6. PubMed ID: 4974643
    [No Abstract]   [Full Text] [Related]  

  • 19. [Primary and secondary resistance in 257 cases of pulmonary tuberculosis from 1964 to 1966 at the Pneumology Service in Poitiers].
    Rautlin de la Roy Y DE; Beauchant G; Brisou J; Dussouil P; Charpentier
    Rev Tuberc Pneumol (Paris); 1967 Nov; 31(7):1054-9. PubMed ID: 4317484
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in the bacteriologic findings in patients treated with rifomycin, alone or associated with other drugs].
    Delli Veneri F; Centrella G; Stefanelli R
    Arch Tisiol Mal Appar Respir; 1968 May; 23(5):387-98. PubMed ID: 4979475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.